generic sales boom in france
TRANSCRIPT
PharmacoEconomics & Outcomes News 256 - 1 Apr 2000
Generic sales boom in FranceSales of nonbranded generic pharmaceutical products
in France have skyrocketed in the 6 months followingthe introduction of a law in that country allowingpharmacists to substitute generic medicines forprescription brandname products, reports thePharmaceutical Journal.
Priced at about 30–40% below equivalent brandnameproducts, generic sales are expected to grow by around£300 million this year, up from a turnover value of about£60 million in 1998. Generic sales have beenparticularly noticeable for certain medicines, includingamoxicillin, for which generic versions of the drugaccount for 52% of total sales, and atenolol, for which22% of sales are from generic products.
Generic sales still represent only 2% of the Frenchpharmaceutical market, compared with 40% in the USand 15% in the UK, notes the report.France benefits from new generic substitution rules. Pharmaceutical Journal 264:427, 18 Mar 2000 800817067
1
PharmacoEconomics & Outcomes News 1 Apr 2000 No. 2561173-5503/10/0256-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved